Indivi

Private

BaselHealthcare & Life Scienceshttps://indivi.io

Last Round

VC Round

Nov 12, 2025

Est. Valuation

$175.41M

Company Overview

Indivi is a medical technology company that develops digital biomarkers for clinical research and patient monitoring, enabling precision medicine in neuroscience research and development.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Drug Discovery, Health IoT, Healthcare Analytics, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Data as a Service

AI Layer

Application

Keywords

digital biomarkersneuroscience clinical trialsdigital biomarker platformTechBiodigital endpointsSoftware as a Medical DeviceSaMDsmartphone sensingdecentralized clinical trialsmedical AIeCOACNS trialsgamified cognitive assessmentsdrug development accelerationMultiple SclerosisParkinson's diseaseAlzheimer's diseaseDigital CRO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Indivi Comparables

Compare Indivi with similar companies based on industry and business-model similarity.

Indivi comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Koneksa Health	84%
Altoida, Inc.	83%
Cumulus Neuroscience	78%

View all Comparables

Indivi Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Nov 12, 2025
Early Funding	Aug 31, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Corne de Jong

Chief Financial Officer

Executive Team

Simone Rey-Riek

Chief Operating Officer

Executive Team

Indivi Investors

Notable investors and investment history

Indivi investors
Investor	Rounds
Zühlke Ventures	Early Funding
Ava Investors	VC Round
Leclercq American Capital	VC Round
Lichtsteiner Foundation	Early Funding

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 24, 2026
Grew 17% QoQ, from 66 to 77 employees.
May 27, 2024
Grew 21% QoQ, from 47 to 57 employees.

View all signals

Indivi Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Indivi Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Indivi's valuation, stock price, and market status.

Firmographic Details

HeadquartersBasel

Employee Range81

Year Founded2012

Last FundingNov 12, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.